NewsBenzingaEli Lilly Announces FDA Approval Of Inluriyo In Combination With Verzenio For Treatment Of Adults With ER+, HER2–, ESR1-Mutated Locally Advanced Or Metastatic Breast Cancer Eli Lilly Announces FDA Approval Of Inluriyo In Combination With Verzenio For Treatment Of Adults With ER+, HER2–, ESR1-Mutated Locally Advanced Or Metastatic Breast Cancer Benzinga 2026.09.18 17:58 (GMT+0) Open on Benzinga Other news HSBC Downgrades Netflix to Hold, Lowers Price Target to $76 Stephens & Co. Maintains Equal-Weight on Cal-Maine Foods, Lowers Price Target to $80 Bitcoin Cash, Uniswap Surges as CME Announces New Futures Contracts: What's Going On? A CEO Shakeup Just Tanked This Stock. How to Play It Here. Twilio Stock Jumps As Analysts See AI Agents Dialing Up Growth Oppenheimer Reiterates Outperform on Tyra Biosciences, Lowers Price Target to $40
